Main Topics

Cemiplimab-rwlc has been approved by the FDA for non-small cell lung cancer with high PD-L1 expression

August 2021: The FDA approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) (locally advanced...

Cemiplimab-rwlc has been approved by the FDA for the treatment of locally progressed and metastatic basal cell carcinoma

August 20, 2021: The FDA has given cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) regular approval for patients with locally advanced basal cell carcinoma (laBCC) who have...

The FDA has approved the first targeted therapy for a lung cancer mutation that was previously thought to be drug-resistant

August 20, 2021: Recently in May, 2021 Lumakras (sotorasib) was approved by the US Food and Drug Administration as the first treatment for adult patients...

Updated guidelines for food and physical activities for cancer patients

July 2021: The American Cancer Society has modified its cancer preventive diet and physical activity guidelines. A person’s lifetime risk of acquiring or dying from...

Pembrolizumab approved for use in any cancer with a high tumor mutational burden

July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a...

Liver cancer surgery and transplant by Dr. Selvakumar

July 14, 2021: Check out interview of Dr. Selvakumar Naganathan – Clinical Lead – Liver transplantation and HPB surgery, Apollo Hospitals, Chennai. Check out the video...

Atezolizumab plus Bevacizumab for treatment of liver cancer

July 13th 2021: A novel medication for people with a kind of liver cancer called hepatocellular carcinoma is available that appears to be better than...

Beta Thalassemia and its consideration with COVID-19

July 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein that...

Breyanzi – New CAR T-Cell therapy from BMS

July 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), a novel CD19-directed chimeric antigen receptor (CAR) T cell treatment developed by Bristol Myers Squibb (BMS), has been approved...

Easily adoptable methods to improve outcomes in treatment of gastroesophageal cancers

July 9th 2021: During the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, two scientists from Roswell Park Comprehensive Cancer Center...

More than 12% of newly diagnosed lung cancer patients newer smoked cigarettes – study suggests

July 7th 2021 : Tobacco smoking is the leading cause of lung cancer, accounting for over 80% of all fatalities from the disease. People who...

Colorectal cancer latest screening guidelines

July 6th 2021 : Colorectal cancer is the among most prevalent cause of cancer death in the the world. Regular screening, on the other hand, can...

Need help? Our team is ready to assist you.

We wish a speedy recovery for your loved ones.

Scan the code